Skip to Content

Safeguard Your Intellectual Property ®

Category: Pharma + Hatch-Waxman

SSJR Successfully Secures Dismissal of Patent Infringement Case

SSJR is pleased to report it has successfully secured a dismissal of a Hatch-Waxman patent infringement case against its client Sandoz. The case was initiated when GlaxoSmithKline (“GSK”) asserted that Sandoz’s generic version of GSK’s anti-nausea drug Zofran® (Ondansetron) infringed U.S. Patent No. 5,344,658. Through its work SSJR was successful in convincing GSK to dismiss its […]

Read More

May 15, 2007 by in IP Litigation